CION Ameerpet
Screening Guide · Reviewed by CION Oncologists · NABH Accredited
Co-Testing Explained — Pap Smear and HPV Test Together
Co-testing means running both cervical screening tests on the same sample of cells: the Pap smear that examines the cells, and the HPV DNA test that looks for the virus behind almost every cervical cancer. You are examined once, the brush goes into one vial, and the laboratory answers two questions instead of one. It is used mainly in women aged 30 to 65, and when both results come back negative it earns the longest safe gap in cervical screening — usually five years before you need to think about it again. This guide explains all four possible result combinations and what each one leads to, with co-testing available at all 7 NABH-accredited CION locations in Hyderabad.
- Two tests, one examination — nothing extra is done to you, the difference is in the laboratory
- Four possible outcomes — and only one of them ordinarily leads straight to colposcopy
- A double negative is the strongest result — the lowest short-term risk any routine screening result can give you
- 45-minute consultation — with a woman doctor available on request, at every CION location
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
What Co-Testing Actually Is
Cervical screening has two instruments. Cytology — the Pap smear — inspects the cells for change that has already begun. The high-risk HPV DNA test looks for the virus that drives that change, often years before any cell looks different. Co-testing simply declines to choose between them: both are performed on the same collected sample, at the same time.
Practically, nothing about your appointment changes. A speculum is passed, a soft brush sweeps the surface of the cervix, and the cells go into a vial of preservative fluid. Whether the laboratory then runs one test or two is invisible to you. The difference shows up in the report, which carries two lines instead of one, and in what those two lines together are allowed to mean.
Co-testing is not the same as reflex testing
The two are frequently confused. In reflex testing, cytology is run first and an HPV test is added only if the smear comes back borderline — the second test is a tie-breaker. In co-testing, both are run upfront regardless of what either shows. Reflex testing costs less and answers a narrower question; co-testing costs more and gives you the full picture on day one. Both are legitimate, and neither is a substitute for turning up.
Why anyone bothers running both
Each test misses something the other catches. Cytology can be normal while a high-risk infection is quietly established; conversely, a small number of significant lesions — particularly glandular ones, which arise higher in the cervical canal — are found on cytology when the HPV test is negative. Running both narrows that gap, which is why a negative co-test is treated as the most reassuring routine result in cervical screening. If you are still weighing one test against the other, start with HPV test vs Pap smear.
Did You Know? Modern follow-up after screening is no longer decided by the result alone. The ASCCP risk-based management consensus guidelines work on the principle of equal management for equal risk: your current result is combined with your previous results to estimate the chance of high-grade precancer, and the same estimated risk leads to the same recommendation whichever combination of tests produced it. That is why two women with an identical report can correctly be given different advice — their histories differ. Sources: ASCCP Risk-Based Management Consensus Guidelines; WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions, 2nd edition.
The Four Possible Results, and What Each One Means
A co-test report has two lines. There are only four ways they can combine, and three of the four are not causes for alarm.
Best case
HPV Negative · Pap Normal
No high-risk virus, no cell change. This is the double negative, and it carries the lowest short-term risk of any routine screening result. Nothing further is needed and the interval to your next test is the longest available, generally about five years.
Common
HPV Positive · Pap Normal
The virus is present but the cells have not changed. Very common, and not a diagnosis of anything. If HPV 16 or 18 is reported, colposcopy is usually arranged directly. For other high-risk types, most protocols repeat the co-test in about twelve months, because many of these infections clear in that time.
Uncommon
HPV Negative · Pap Abnormal
Cell change without detectable high-risk virus. For borderline change this is usually low-risk and managed by repeating the tests rather than by colposcopy. For high-grade or glandular abnormality it is taken seriously regardless of the negative HPV result, and colposcopy follows.
Needs colposcopy
HPV Positive · Pap Abnormal
Both signals agree. This is the combination that ordinarily leads straight to colposcopy and, if an abnormal area is seen, a small biopsy. It still does not mean cancer — most of what is found at this stage is precancerous change treatable in one outpatient visit.
Also possible
Unsatisfactory Sample
Occasionally there are too few cells, or blood and inflammation obscure the slide, and the cytology cannot be reported. This is a technical problem, not a finding. The test is simply repeated, usually after a few weeks.
Remember
None of the Four Is a Diagnosis
A co-test sorts women into groups by risk. What confirms or excludes disease is colposcopy and biopsy. Read the cervical cancer overview for how the whole sequence fits together, from infection to precancer to cancer.
If your own report shows a positive HPV line, the page that answers the question you are really asking is what a positive HPV result means.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Two Answers From One Appointment
Co-testing takes no longer than a single smear and tells you both what the virus is doing and what the cells are doing. Same-week appointments across Hyderabad, woman doctor on request.
Who Co-Testing Suits — and Who It Does Not
More information is not automatically better. A test that finds more also refers more women for follow-up they did not need, and that has its own costs in anxiety, appointments and money. Here is where the balance falls.
It suits women aged 30 to 65 who want the longest safe interval
This is the classic use. Above 30, a positive HPV result is far more likely to represent a persistent infection that matters, so the extra information is genuinely actionable — and a double negative earns a five-year gap with a clear conscience. It also suits women who travel, who find it hard to attend regularly, or who simply want the most complete answer available in one sitting.
It suits women with an incomplete or unknown screening history
If you cannot remember when you were last tested, or your previous results were never followed up, a co-test resolves the uncertainty in one visit rather than two. It is also useful after the menopause, when sampling can be harder and a cytology-only result carries a little less weight.
It is not the right first choice under 30
High-risk HPV is very common in the twenties and usually clears on its own. Adding an HPV test at that age mostly produces positive results that lead to follow-up finding nothing, and repeated treatment of the cervix is not harmless — it is associated with a higher risk of preterm birth in later pregnancies. Cytology alone remains the sensible first test in that decade.
It is not a substitute for follow-up you are already under
If you are being monitored after an abnormal result or after treatment for precancer, that surveillance schedule is not routine screening and should not be swapped for a co-test at your own initiative. Keep the plan you were given, and raise any change with the clinician who wrote it.
On availability in India: co-testing is widely offered in private laboratories and hospitals, including across Hyderabad, but it is not what the national programme runs. Public screening is built around visual inspection with acetic acid for women aged 30 to 65, because it needs no laboratory and can be delivered close to home. That is a resource decision, not a verdict on which test is better — and it is why VIA screening is worth understanding even if you intend to pay for something more sensitive.
How Soon You Come Back
The interval after a co-test is decided by the combination of results and by your history, not by the calendar alone. This table shows the usual pattern; your own plan may differ, and the report you are given should say so explicitly.
| Your co-test result | Usual next step | Typical timing |
|---|---|---|
| HPV negative, cytology normal | Routine screening, nothing further | About five years |
| HPV positive for type 16 or 18 | Colposcopy, whatever the cytology shows | Within weeks |
| HPV positive, other high-risk type, cytology normal | Repeat co-test rather than immediate colposcopy | About twelve months |
| HPV negative, borderline cytology | Repeat testing; colposcopy is usually not needed | Around one to three years, depending on history |
| High-grade or glandular cytology, any HPV result | Colposcopy, and biopsy if an abnormal area is seen | Without delay |
| Unsatisfactory sample | Repeat the sample — this is not an abnormal result | A few weeks later |
| Any result, with symptoms | Examination of the cervix regardless of what the screening says | Now, not at the next interval |
Intervals for cytology-only and HPV-only screening are set out in how often to get a Pap smear. If screening ever leads to a confirmed diagnosis, our cervical cancer treatment in Hyderabad page explains how a plan is built by the tumour board, in line with NCCN, FIGO and ESMO guidance.
Did You Know? The reason a negative co-test buys five years rather than one is the long natural history of the disease. Persistent high-risk HPV typically takes 10 to 15 years to progress through precancerous change to invasive cancer, so a woman with no virus and no cell change today has almost no plausible route to cancer within the next few years. The interval is not a compromise on safety — it is arithmetic drawn from how slowly this cancer develops. Source: WHO Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem.
Why Women in Hyderabad Screen at CION
A two-line report deserves more than a courier envelope. Every result at CION is explained by the person who can act on it.
Woman doctor available on request
Pap and HPV from a single sample
Every report explained in person
45-minute detailed consultation
On-site colposcopy and biopsy
Tumour board for every cancer diagnosis
7 NABH-accredited Hyderabad locations
Transparent, itemised costs
4.8 / 5 Google rating
Take The Next Step
Get Both Answers, and Then Stop Worrying
For most women, a co-test ends with two negative lines and five years of not having to think about it. That is a good outcome, and it starts with one short appointment.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Co-Testing (Pap + HPV) — Frequently Asked Questions
What is the difference between co-testing and a reflex HPV test?
Co-testing runs cytology and a high-risk HPV test on your sample at the same time, whatever either one shows. Reflex testing runs cytology first and only adds the HPV test if the smear comes back borderline, using it as a tie-breaker to decide whether follow-up is needed. Both are done from the same vial and neither involves a second examination. Co-testing gives you the complete picture immediately and costs more; reflex testing costs less and answers a narrower question. Which one you are offered often depends on the laboratory protocol as much as on your own circumstances, so it is reasonable to ask which is being ordered.
Both lines of my co-test are negative. When is my next test due?
A double negative is the strongest routine reassurance cervical screening can give, and it usually earns an interval of about five years. The logic is the slow natural history of the disease: persistent high-risk HPV generally takes ten to fifteen years to progress to invasive cancer, so a woman with no detectable virus and no cell change has almost no plausible route to cancer within the next few years. Two cautions. The interval applies to routine screening, not to follow-up after a previous abnormality. And it applies only while you have no symptoms — bleeding after sex or after the menopause is examined regardless of when you were last screened.
My HPV test was negative but the Pap smear was abnormal. Is that a mistake?
No, and it is not unusual. The two tests measure different things, so they can genuinely disagree. Borderline cell change with a negative high-risk HPV result is a low-risk combination and is normally managed by repeating the tests rather than by sending you for colposcopy. High-grade or glandular abnormality is treated differently: it goes to colposcopy even when the HPV result is negative, because a small number of significant lesions — particularly glandular ones that arise higher in the cervical canal — are not accompanied by a detectable high-risk virus in the sample taken.
Is co-testing available in India, and does the government programme use it?
It is widely available in private laboratories and hospitals, including across Hyderabad, and it is what many women in cities are offered when they pay for screening. The national programme does not use it. Public cervical screening in India is built around visual inspection with acetic acid for women aged 30 to 65, because it requires no laboratory, gives an immediate result and can be delivered at a health and wellness centre close to home. That is a decision about reach and resources rather than a judgement that co-testing is unnecessary — the priority in a country where most women have never been screened at all is a first test, not the most sensitive test.
Is co-testing worth the extra cost compared with a single test?
It costs more than either test alone, because two laboratory processes are billed rather than one. Whether that is worth it depends on your age and your history. Above 30, with an uncertain or incomplete screening history, or after the menopause when sampling can be harder, the extra information often changes what happens next and the five-year interval after a double negative offsets some of the cost over time. Below 30 it is usually poor value, because a positive HPV result at that age mostly reflects an infection that will clear. Ask for an itemised estimate first — at CION you are told what each test costs before it is ordered.
Medical disclaimer: This page is general health information, reviewed by a CION oncologist. Result combinations and intervals described here are general guidance and cannot replace the plan written for you after your own test. If you have symptoms, or a report you do not understand, please see a doctor rather than relying on any website.